Lv31
250 积分 2023-02-28 加入
Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis
4小时前
待确认
Safety of antisense oligonucleotide and siRNA-based therapeutics
1个月前
已完结
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
1个月前
已完结
A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet
1个月前
已完结
Immunostimulatory Oligonucleotides
1个月前
已完结
Frameworks for transformational breakthroughs in RNA-based medicines
1个月前
已完结
Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver
1个月前
已完结
Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop
1个月前
已完结
The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy
1个月前
已完结
Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy
1个月前
已完结
皖公网安备34019202002308
